Dietary antioxidants and other dietary factors in the etiology of Parkinson's disease
β Scribed by Dr. W. L. Scheider; L. A. Hershey; J. E. Vena; T. Holmlund; J. R. Marshall; J. L. Freudenheim
- Publisher
- John Wiley and Sons
- Year
- 1997
- Tongue
- English
- Weight
- 731 KB
- Volume
- 12
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
It has been suggested that dietary antioxidants reduce Parkinson's disease (PD) risk by neutralizing free radicals, thus preventing injury to neurons in the substantia nigra. This caseβcontrol study examined the possible role of longβterm dietary antioxidant intake in PD etiology. Cases (n = 57) were males 45β79 years old with at least two cardinal signs of PD and no evidence of other forms of parkinsonism or dementia. Ageβmatched friend controls (n = 50) were chosen from lists provided by the cases. Usual dietary intake 20 years ago, including vitamins E and C and carotenoids, was assessed by a 102βitem food frequency questionnaire. Odds ratios and 95% confidence intervals were calculated using conditional logistic regression. Antioxidant intake, adjusted for age, education, smoking, rural living, and total energy intake, was not associated with reduced PD risk. Trends toward greater PD risk were associated with higher intakes of vitamin C and carotenoids, especially xanthophylls, reflecting higher intakes by PD cases of fruit and certain vegetables. Intakes of sweet foods, including fruit, were associated with higher PD risk, suggesting that the observed trends may be due to a preference for sweet foods. This study does not provide support for a protective effect of longβterm dietary antioxidant intake on PD risk.
π SIMILAR VOLUMES
In this review, the role of dietary antioxidants in the prevention of hepatocarcinogenesis is examined. Both human and animal models are discussed. Vitamin C, vitamin E, and selenium are antioxidants that are essential in the human diet. A number of non-essential chemicals also contain antioxidant a
The morning session will focus on the Etiology, Pathogenesis, and Treatment of Parkinson's Disease. It consists of a keynote speaker and 10 presentations by the following individuals with allotted time for questions and answers after each presenter.